文献速递糖尿病

近62万糖尿病患者的疫苗接种组学全景

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在意大利伦巴第地区618396例糖尿病患者和9534087例非糖尿病者中,回顾性分析2021年9月至2022年9月流感、脑膜炎球菌、肺炎球菌和带状疱疹疫苗的接种覆盖率及死亡与住院情况。糖尿病患者中流感疫苗接种率44.6%、肺炎球菌10.9%、抗脑膜炎球菌2.5%、抗带状疱疹0.7%;接种流感、带状疱疹和脑膜炎球菌疫苗者死亡风险约降低2倍且住院减少。

要点

  • 糖尿病患者流感疫苗接种率为44.6%,肺炎球菌疫苗为10.9%。
  • 接种流感、带状疱疹及脑膜炎球菌疫苗者整体死亡风险约降低2倍。
  • 老年糖尿病患者接种上述疫苗后死亡风险降低约3倍且住院减少。

核心结论

  • 糖尿病患者免疫接种覆盖率仍远低于推荐目标。
  • 流感疫苗接种使近3800/10万糖尿病患者免于死亡风险。
  • 接种患者死亡和住院总体显著减少,支持扩大糖尿病患者的疫苗接种组学全景。

研究设计与样本

  • 回顾性分析意大利伦巴第地区2021年9月至2022年9月618396例糖尿病患者和9534087例非糖尿病者的公共计算机登记疫苗接种覆盖率、死亡和住院数据。

主要发现

  • 糖尿病患者中44.6%接种流感疫苗、10.9%接种肺炎球菌疫苗、2.5%接种抗脑膜炎球菌疫苗、0.7%接种抗带状疱疹疫苗。
  • 接种流感、带状疱疹和脑膜炎球菌疫苗的糖尿病患者总体死亡风险约降低2倍且住院减少。
  • 老年糖尿病患者接种流感、带状疱疹和脑膜炎球菌疫苗后死亡风险约降低3倍,心脏和肺部原因住院均减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 1 (T1D) and type 2 diabetes (T2D) are associated with an elevated incidence of infectious diseases and a higher risk of infections-related hospitalization and death. OBJECTIVE: In this study, we delineated the "vaccinome" landscape obtained with a large immunization schedule offered by the Regional Government of Lombardy in a cohort of 618 396 patients with diabetes (T1D and T2D). METHODS: Between September 2021 and September 2022, immunization coverage for influenza, meningococcus, pneumococcus, and herpes zoster was obtained from the public computerized registry of the health care system of Lombardy Region (Italy) in 618 396 patients with diabetes and in 9 534 087 subjects without diabetes. Type of diabetes, age, mortality, and hospitalizations were retrospectively analyzed in vaccinated and unvaccinated patients. RESULTS: Among patients with diabetes (T1D and T2D), 44.6% received the influenza vaccine, 10.9% the pneumococcal vaccine, 2.5% the antimeningococcus vaccine, and 0.7% the antizoster vaccine. Patients with diabetes immunized for influenza, zoster, and meningococcus showed a 2-fold overall reduction in mortality risk and a decrease in hospitalizations. A 3-fold lower risk of mortality and a decrease in hospitalizations for both cardiac and pulmonary causes were also observed after influenza, zoster, and meningococcus immunization in older patients with diabetes. CONCLUSION: Immunization coverage is still far from the recommended targets in patients with diabetes. Despite this, influenza vaccination protected nearly 3800 per 100 000 patients with diabetes from risk of death. The overall impressive decrease in mortality and hospitalizations observed in vaccinated patients strengthens the need for scaling up the "vaccinome" landscape in patients with diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. D'Addio F, Lazzaroni E, Lunati ME, et al. Vaccinome Landscape in Nearly 620 000 Patients With Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39040010. doi:10.1210/clinem/dgae476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。